Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
8.14
-0.05 (-0.61%)
At close: Nov 20, 2024, 4:00 PM
8.23
+0.09 (1.11%)
Pre-market: Nov 21, 2024, 7:14 AM EST
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 557 employees as of December 31, 2023. The number of employees increased by 54 or 10.74% compared to the previous year.
Employees
557
Change (1Y)
54
Growth (1Y)
10.74%
Revenue / Employee
$163,120
Profits / Employee
-$736,081
Market Cap
2.48B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PACS Group | 32,433 |
Amneal Pharmaceuticals | 7,850 |
QuidelOrtho | 7,100 |
Privia Health Group | 1,102 |
Vericel | 314 |
SpringWorks Therapeutics | 305 |
Catalyst Pharmaceuticals | 167 |
Apogee Therapeutics | 91 |
IOVA News
- 9 days ago - Iovance Biotherapeutics Q3: A Beat, But A Selloff - Now A Buy Opportunity - Seeking Alpha
- 13 days ago - Iovance Biotherapeutics, Inc. (IOVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024 - GlobeNewsWire
- 20 days ago - Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024 - GlobeNewsWire
- 6 weeks ago - Iovance Biotherapeutics: Moving To The Next Phase - Seeking Alpha
- 2 months ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 3 months ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Iovance's Tumor-Fighting TILs Are Just Warming Up (Rating Upgrade) - Seeking Alpha